What's the best variant annotation platform for prioritizing rare disease variants from whole-genome sequencing?

There isn’t a single universally “best” platform, but for prioritizing rare disease variants from whole-genome sequencing (WGS), the strongest options are usually:

Top practical choices

1. Seqr / VariantMatcher-style clinical research platforms

• Best for: rare disease cohort analysis, trio interpretation, collaborative filtering, phenotype-driven prioritization.
• Why it stands out: combines variant filtering, gene/phenotype matching, and inheritance pattern analysis well.
• Strong point: excellent for Mendelian rare disease workflows, especially in research/diagnostic settings.

2. Fabric / Franklin / Alissa Interpret / Cartagenia-type clinical interpretation systems

• Best for: lab-grade clinical interpretation, ACMG/AMP classification, case management.
• Why it stands out: structured variant curation, evidence tracking, clinical reporting.
• Strong point: better if your goal is diagnostic reporting rather than discovery.

3. VarSome Clinical

• Best for: fast variant interpretation with rich annotation.
• Why it stands out: broad annotation integration, ACMG support, user-friendly interface.
• Strong point: good general-purpose platform, especially for smaller teams.

If you mean “best for discovering the causal rare variant in WGS”

A good rare-disease prioritization setup usually combines:

• Variant annotation: VEP or snpEff
• Phenotype-driven prioritization: Exomiser
• Clinical interpretation: Seqr / Franklin / VarSome / Alissa
• Population filtering: gnomAD, local controls
• Genome-specific support: SV/CNV caller annotations, noncoding/regulatory analysis

My short recommendation

• For rare disease gene discovery in WGS: Exomiser + Seqr is often an excellent combo.
• For clinical variant curation/reporting: Franklin, Alissa Interpret, or VarSome Clinical.
• For collaborative Mendelian analysis at scale: Seqr is one of the strongest.

Important caveat

For WGS rare disease cases, the “best” platform is the one that also handles:

• SVs/CNVs
• deep intronic/noncoding variants
• trio inheritance
• phenotype terms (HPO)
• ACMG evidence and audit trail

If you want, I can give you a ranked comparison table of the main platforms based on:

• research vs clinical use
• trio analysis
• SV/CNV support
• phenotype prioritization
• ACMG interpretation
• ease of use/price